Publisher
Springer Science and Business Media LLC
Reference87 articles.
1. National Cancer Institute. SEER Cancer Stat Fact Sheets: Prostate Cancer. National Institutes of Health
https://seer.cancer.gov/statfacts/html/prost.html
(2018).
2. Huggins, C. & H. C. Studies in Prostate Cancer. Cancer Res. 1, 293–297 (1941).
3. Loblaw, D. A. et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J. Clin. Oncol. 25, 1596–1605 (2007).
4. Borgmann, V., Hardt, W., Schmidt-Gollwitzer, M., Adenauer, H. & Nagel, R. Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach? Lancet 1, 1097–1099 (1982).
5. Sharifi, N., Gulley, J. L. & Dahut, W. L. Androgen deprivation therapy for prostate cancer. JAMA 294, 238–244 (2005).
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献